您的购物车当前为空
Vosoritide acetate是一种基于C-type natriuretic peptide类似物设计的多肽药物,可通过激活Natriuretic peptide receptor-B促进cGMP生成,同时拮抗FGFR3信号通路对骨生长的抑制作用,已用于治疗软骨发育不全等生长障碍疾病。
别名 伏索利肽乙酸盐, BMN-111 acetate, BMN111 acetate, BMN 111 acetate
Vosoritide acetate是一种基于C-type natriuretic peptide类似物设计的多肽药物,可通过激活Natriuretic peptide receptor-B促进cGMP生成,同时拮抗FGFR3信号通路对骨生长的抑制作用,已用于治疗软骨发育不全等生长障碍疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,320 | 现货 | |
| 5 mg | ¥ 3,290 | 现货 | |
| 10 mg | ¥ 4,730 | 现货 | |
| 25 mg | ¥ 7,260 | 现货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Vosoritide acetate is a peptide drug designed based on a C-type natriuretic peptide analog. Vosoritide acetate promotes cGMP production by activating the natriuretic peptide receptor-B while antagonizing the inhibitory effects of the FGFR3 signaling pathway on bone growth. Vosoritide acetate is currently used to treat growth disorders such as achondroplasia. |
| 别名 | 伏索利肽乙酸盐, BMN-111 acetate, BMN111 acetate, BMN 111 acetate |
| 分子量 | 4162.78 |
| 分子式 | C176H290N56O51S3.C2H4O2 |
| Sequence | Pro-Gly-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys (Disulfide bridge:Cys23-Cys39) |
| Sequence Short | PGQEHPNARKYKGANKKGLSKGCFGLKLDRIGSMSGLGC (Disulfide bridge:Cys23-Cys39) |
| 存储 | Keep away from moistureKeep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | |||||||||||||||||||||||||
| 溶解度信息 | H2O: 100 mg/mL (24.02 mM) | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
H2O
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | ||||||||||||||||||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多